Cronos Group stock has earnings due November 5, 2026
Published on 10/15/2026 at 22:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQuarterly results guide the calendar
- Cronos Group scheduled its third-quarter 2026 earnings call for November 5, 2026.
- Revenue reached USD 53.01 million in the second quarter of 2026.
- Cronos Group stock costs EUR 2.85 at Lang & Schwarz on October 15, 2026 at 10:45 p.m. CEST, with Nasdaq shares up 1.27 percent on the day.
- Cronos Group trades at a P/E ratio of 17.06.
Cronos Group (ISIN CA22717L1013) has scheduled its third-quarter 2026 earnings call for November 5, 2026, according to Cronos Group. The date gives investors the next fixed checkpoint after second-quarter revenue reached USD 53.01 million, up 58 percent from a year earlier, as Investing.com reported on October 13, 2026. Cronos Group stock was at EUR 2.85 at Lang & Schwarz on October 15, 2026 at 10:45 p.m. CEST; the Nasdaq listing was up 1.27 percent on the day.
Second-quarter growth sets the baseline
The second-quarter numbers provide the clearest operating reference before the November call. Gross profit was USD 28.45 million and the gross margin was 54.00 percent for the quarter ended June 30, 2026. Operating cash flow reached USD 24.01 million in the same period, giving the results a cash-generation angle alongside the revenue increase.
Price position and current range
Cronos traded between USD 2.28 and USD 3.61 over the 52 weeks through October 15, 2026. Its current Nasdaq price of USD 3.20 stood 11.36 percent below the yearly high, while the year-to-date gain was 27.00 percent through September 18, 2026. The company completed the CanAdelaar acquisition on October 15, 2026 for a base purchase price of EUR 57.50 million, according to StockTitan.
Valuation and November date
Cronos had a market capitalization of USD 1.2 billion and a P/E ratio of 17.06 as of October 15, 2026. The company paid no trailing dividend, while the November 5 earnings call is the next explicitly scheduled corporate date. The calendar puts the next detailed update less than three weeks away.
Comparison with peers
- CRON (Nasdaq, USD): plus 1.27 percent, P/E 17.06, market capitalization USD 1.2 billion.
- Canopy Growth (Nasdaq, USD): plus 2.91 percent, P/E minus 1.56, market capitalization USD 311.1 million.
- Tilray Brands (Nasdaq, USD): plus 2.23 percent, P/E minus 2.29, market capitalization USD 359.0 million.
What the next report can clarify
The November results can show whether the 58 percent second-quarter revenue increase was sustained and how the CanAdelaar transaction is being integrated. For investors, the key comparison will be revenue growth against the 54.00 percent gross margin and USD 24.01 million operating cash flow reported for the second quarter.
Price and investor calendar
At Lang & Schwarz, Cronos Group stock was trading at EUR 2.85 on October 15, 2026 at 10:45 p.m. CEST. On Nasdaq, the stock gained 1.27 percent on October 15, 2026.
The further course of trading is shown by the continuously updated real-time quote of Cronos Group stock.
Cronos Group market data
- Company: Cronos Group Inc.
- ISIN: CA22717L1013
- Ticker: CRON
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 15, 2026, 10:45 p.m. CEST): EUR 2.85
- Nasdaq daily change: plus 1.27 percent on October 15, 2026
- Market capitalization: USD 1.2 billion (as of October 15, 2026)
- 52-week range: USD 2.28-3.61 (as of October 15, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
- Next earnings date: November 5, 2026
Market context: Market report S&P 500.
